• 1. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 2. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 3. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 4. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

Introduction to 4-Cyano-3-methoxybenzoic acid (CAS No. 102362-00-5)

4-Cyano-3-methoxybenzoic acid, identified by the Chemical Abstracts Service Number (CAS No.) 102362-00-5, is a significant compound in the field of organic chemistry and pharmaceutical research. This benzoic acid derivative features both a cyano group and a methoxy group, making it a versatile intermediate in the synthesis of various pharmacologically active molecules. The unique structural properties of this compound contribute to its utility in developing novel therapeutic agents, particularly in the realms of inflammation, pain management, and metabolic disorders.

The 4-cyano-3-methoxybenzoic acid structure is characterized by its aromatic ring system, which is functionalized at the 3-position with a methoxy group (-OCH?) and at the 4-position with a cyano group (-CN). This arrangement imparts distinct electronic and steric properties that influence its reactivity and biological activity. The presence of the cyano group enhances electrophilicity, making it susceptible to nucleophilic substitution reactions, while the methoxy group provides resonance stabilization and influences hydrogen bonding interactions.

In recent years, 4-cyano-3-methoxybenzoic acid has garnered attention in medicinal chemistry due to its role as a precursor in the synthesis of nonsteroidal anti-inflammatory drugs (NSAIDs) and other bioactive compounds. Researchers have explored its derivatives as potential inhibitors of cyclooxygenase (COX) enzymes, which are key targets in managing inflammation and pain. Preliminary studies suggest that certain analogs of this compound exhibit promising anti-inflammatory properties with improved selectivity over traditional NSAIDs.

The pharmaceutical industry has been particularly interested in 4-cyano-3-methoxybenzoic acid for its potential application in treating chronic inflammatory conditions such as rheumatoid arthritis and osteoarthritis. By modifying its chemical structure, scientists have synthesized novel compounds that demonstrate enhanced efficacy and reduced gastrointestinal side effects associated with conventional NSAIDs. These advancements highlight the importance of 3-methoxybenzoic acid derivatives in drug discovery efforts.

Beyond its pharmaceutical applications, 4-cyano-3-methoxybenzoic acid finds utility in agrochemical research as a building block for developing herbicides and pesticides. Its structural features allow for modifications that enhance binding affinity to biological targets, improving the efficacy of crop protection agents. Additionally, the compound has been investigated for its potential role in material science, where its aromatic nature contributes to the development of high-performance polymers and coatings.

The synthesis of 4-cyano-3-methoxybenzoic acid typically involves multi-step organic reactions starting from commercially available aromatic precursors. Common synthetic routes include nitration followed by reduction to introduce the cyano group, followed by methylation at the 3-position. Advances in catalytic methods have enabled more efficient and environmentally friendly synthetic pathways, reducing waste generation and improving yields. These innovations align with global efforts to promote sustainable chemical manufacturing practices.

In academic research, 4-cyano-3-methoxybenzoic acid has been employed as a model compound for studying reaction mechanisms and developing new synthetic methodologies. Its reactivity profile makes it an excellent candidate for exploring transition metal-catalyzed transformations, such as cross-coupling reactions and oxidation processes. Such studies contribute to the broader understanding of organic chemistry principles and pave the way for novel synthetic strategies applicable to other complex molecules.

The biological activity of 4-cyano-3-methoxybenzoic acid has been further explored through computational modeling and high-throughput screening techniques. These approaches have identified novel derivatives with enhanced binding affinity to therapeutic targets, including enzymes and receptors involved in metabolic diseases. By leveraging computational tools alongside experimental validation, researchers can accelerate the discovery process and bring new treatments to market more efficiently.

Future directions in the study of 4-cyano-3-methoxybenzoic acid include investigating its potential as an intermediate in drug development for neurological disorders. Preliminary data suggest that certain derivatives may modulate neurotransmitter systems relevant to conditions such as Alzheimer's disease and Parkinson's disease. These findings underscore the versatility of this compound and its potential impact on multiple therapeutic areas.

The industrial production of 4-cyano-3-methoxybenzoic acid has also seen advancements in process optimization, ensuring scalability while maintaining high purity standards. Manufacturers employ rigorous quality control measures to meet regulatory requirements for pharmaceutical applications. As demand grows for specialized intermediates like this one, collaborations between academia and industry will continue to drive innovation in synthetic chemistry.

In conclusion, 4-cyano-3-methoxybenzoic acid (CAS No. 102362-00-5) is a multifaceted compound with significant applications across pharmaceuticals, agrochemicals, and material science. Its unique structural features enable diverse chemical modifications, making it a valuable tool for researchers seeking to develop novel bioactive molecules. With ongoing advancements in synthetic methodologies and computational biology, the future prospects for this compound remain promising as it continues to play a pivotal role in scientific discovery.

• 89469-52-3(4-Cyano-2-methoxybenzoic acid)
• 258273-32-4(3-Cyano-4-ethoxybenzoic acid)
• 453566-61-5(3-cyano-5-methoxybenzoic acid)
• 174261-09-7(Benzoic acid, 5-cyano-2,4-dimethoxy-)
• 946007-61-0(4-(Benzyloxy)-3-cyanobenzoic acid)
• 117738-82-6(3-Cyano-4-methoxybenzoic acid)
• 1149388-22-6(4-Cyano-2-methyl-3-(methyloxy)benzoic acid)
• 403825-99-0(4-((2-cyanophenoxy)methyl)benzoic acid)
• 838873-20-4(2-Naphthalenecarboxylic acid, 7-cyano-6-methoxy-)
• 21962-49-2(4-Formyl-2-methoxybenzonitrile)